Interspecies Organogenesis for Human Transplantation

Area of Science:

• Regenerative Medicine
• Bioengineering
• Genetics

Background:

• Organ transplantation faces global shortages, driving the need for alternative solutions.
• Regenerative medicine aims to repair or replace damaged tissues and organs.
• Gene editing technologies have advanced rapidly, enabling precise genetic modifications.

Purpose of the Study:

• To review the potential of blastocyst complementation combined with gene editing for generating human organs in livestock.
• To identify candidate genes for knockout to facilitate human organ development in interspecies environments.
• To discuss current regenerative therapies and barriers to successful blastocyst complementation.

Main Methods:

• Review of existing literature on blastocyst complementation and gene editing.
• Identification of organ systems (pancreas, liver, heart, kidney, lung, skeletal muscle, immune, nervous) for potential application.
• Analysis of common causes of organ failure and current regenerative approaches.

Main Results:

• Blastocyst complementation allows exogenous cells to fill developmental niches created by gene knockout.
• Specific gene targets are proposed for enabling the development of human pancreas, liver, heart, kidney, lung, and skeletal muscle within animal hosts.
• Current barriers include technical challenges in gene editing, interspecies developmental incompatibilities, and ethical considerations.

Conclusions:

• Blastocyst complementation holds significant promise for generating functional human organs, potentially alleviating transplant waiting lists.
• Further research is needed to overcome technical and biological hurdles for clinical translation.
• This approach represents a paradigm shift in regenerative medicine with broad implications for treating organ failure.